RAFAEL HOLDINGS, INC. Tax Withholding Paid on Stock Awards
RAFAEL HOLDINGS, INC. (RFL) reported Tax Withholding Paid on Stock Awards of $79.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-04-30 was $19.00K, a 42.42% decline year-over-year.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-01-31 was $32.00K, a 18.52% increase year-over-year.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-10-31 was $28.00K, a 41.67% decline year-over-year.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-07-31 was $107.00K, a 345.83% increase year-over-year.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $215.00K, a 58.09% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $136.00K.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $75.00K, a 59.46% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $185.00K, a 48.00% increase from fiscal 2020.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-04-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $51.00K derived: sum of 2 quarters · filed 2026-06-11 | $79.00K 10-Q · filed 2026-06-11 | $186.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $60.00K 10-Q · filed 2026-03-16 | $167.00K derived: sum of 3 quarters · filed 2026-03-16 | $200.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $28.00K 10-Q · filed 2025-12-12 | $135.00K derived: sum of 2 quarters · filed 2025-12-12 | $168.00K derived: sum of 3 quarters · filed 2026-06-11 | $195.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $140.00K derived: sum of 2 quarters · filed 2026-06-11 | $167.00K derived: sum of 3 quarters · filed 2026-06-11 | $215.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $60.00K derived: sum of 2 quarters · filed 2026-06-11 | $108.00K 10-Q · filed 2026-06-11 | $132.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $75.00K 10-Q · filed 2026-03-16 | $99.00K derived: sum of 3 quarters · filed 2026-03-16 | |
| 2024-10-31 | $48.00K 10-Q · filed 2025-12-12 | $72.00K derived: sum of 2 quarters · filed 2025-12-12 | ||
| 2024-07-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $136.00K 10-K · filed 2025-10-29 | ||
| 2024-04-30 | $112.00K 10-Q · filed 2025-06-11 | |||
| 2022-07-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $4.00K derived: sum of 2 quarters · filed 2022-10-31 | $45.00K derived: sum of 3 quarters · filed 2022-10-31 | $75.00K 10-K · filed 2022-10-31 |
| 2022-04-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $42.00K derived: sum of 2 quarters · filed 2022-06-14 | $72.00K 10-Q · filed 2022-06-14 | $72.00K derived: sum of 4 quarters · filed 2022-10-31 |
| 2022-01-31 | $41.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $71.00K 10-Q · filed 2022-03-17 | $71.00K derived: sum of 3 quarters · filed 2022-10-31 | $110.00K derived: sum of 4 quarters · filed 2022-10-31 |
| 2021-10-31 | $30.00K 10-Q/A · filed 2022-02-28 | $30.00K derived: sum of 2 quarters · filed 2022-10-31 | $69.00K derived: sum of 3 quarters · filed 2022-10-31 | |
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $39.00K derived: sum of 2 quarters · filed 2022-10-31 | $185.00K 10-K · filed 2022-10-31 | |
| 2021-04-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $185.00K 10-Q · filed 2022-06-14 | ||
| 2021-01-31 | $146.00K 10-Q · filed 2022-03-17 | |||
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $9.00K derived: sum of 2 quarters · filed 2021-10-18 | $125.00K 10-K · filed 2021-10-18 | |
| 2020-04-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $125.00K 10-Q · filed 2021-06-14 | ||
| 2020-01-31 | $116.00K 10-Q · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |